Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: a multicentre US study. (отвара нови прозор)

Al-Samkari H, Jiang D, Gernsheimer T, Liebman H, Lee S, Wojdyla M, Vredenburg M, Cuker A

Извор‎: Br J Haematol. 2022;197(3):359-66.

Индекс‎: PubMed 35179784

DOI‎: 10.1111/bjh.18081

https://pubmed.ncbi.nlm.nih.gov/35179784/ (отвара нови прозор)

Efficacy of high-dose methylprednisolone as a first-line therapy in adult patients with idiopathic thrombocytopenic purpura. (отвара нови прозор)

Alpdogan O, Budak-Alpdogan T, Ratip S, Firatli-Tuglular T, Tanriverdi S, Karti S, Bayik M, Akoglu T.

Извор‎: Br J Haematol 1998;103(4):1061-3.

Индекс‎: PubMed 9886319

https://www.ncbi.nlm.nih.gov/pubmed/9886319 (отвара нови прозор)

Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. (отвара нови прозор)

Arnold DM, Dentali F, Crowther MA, Meyer RM, Cook RJ, Sigouin C, Fraser GA, Lim W, Kelton JG.

Извор‎: Ann Intern Med 2007;146(1):25-33.

Индекс‎: PubMed 17200219

https://www.ncbi.nlm.nih.gov/pubmed/17200219 (отвара нови прозор)

Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial. (отвара нови прозор)

Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Amini S, Schipperus M, Lim W, Vishnu P, Warner M, Carruthers J, Li N, Lane S, Kelton JG

Извор‎: Lancet Haematol 2020;7(9):e640-8.

Индекс‎: PubMed 32853584

DOI‎: 10.1016/S2352-3026(20)30227-1

https://www.ncbi.nlm.nih.gov/pubmed/32853584 (отвара нови прозор)

A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. (отвара нови прозор)

Blanchette VS, Luke B, Andrew M, Sommerville-Nielsen S, Barnard D, de Veber B, Gent M.

Извор‎: J Pediatr 1993;123(6):989-95.

Индекс‎: PubMed 8229536

https://www.ncbi.nlm.nih.gov/pubmed/8229536 (отвара нови прозор)

High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults. (отвара нови прозор)

Borst F, Keuning JJ, van Hulsteijn H, Sinnige H, Vreugdenhil G.

Извор‎: Ann Hematol 2004;83(12):764-8.

Индекс‎: PubMed 15309522

DOI‎: 10.1007/s00277-004-0908-1

https://www.ncbi.nlm.nih.gov/pubmed/15309522 (отвара нови прозор)

Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. (отвара нови прозор)

British Committee for Standards in Haematology General Haematology Task Force.

Извор‎: Br J Haematol 2003;120(4):574-96.

Индекс‎: PubMed 12588344

https://www.ncbi.nlm.nih.gov/pubmed/12588344 (отвара нови прозор)

IVMP+IVIG raises platelet counts faster than IVIG alone: results of a randomized, blinded trial in childhood ITP. (отвара нови прозор)

Carcao M, Silva M, David M, Klaassen RJ, Steele M, Price V, Wakefield C, Kim L, Stephens D, Blanchette VS

Извор‎: Blood Adv 2020;4(7):1492-1500.

Индекс‎: PubMed 32282882

DOI‎: 10.1182/bloodadvances.2019001343

https://www.ncbi.nlm.nih.gov/pubmed/32282882 (отвара нови прозор)

Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. (отвара нови прозор)

Cheng Y, Wong RS, Soo YO, Chui CH, Lau FY, Chan NP, Wong WS, Cheng G.

Извор‎: N Engl J Med 2003;349(9):831-6.

Индекс‎: PubMed 12944568

DOI‎: 10.1056/NEJMoa030254

https://www.ncbi.nlm.nih.gov/pubmed/12944568 (отвара нови прозор)

How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment. (отвара нови прозор)

Ghanima W, Godeau B, Cines DB, Bussel JB.

Извор‎: Blood 2012;120(5):960-9.

Индекс‎: PubMed 22740443

DOI‎: 10.1182/blood-2011-12-309153

https://www.ncbi.nlm.nih.gov/pubmed/22740443 (отвара нови прозор)

Use of eltrombopag for secondary immune thrombocytopenia in clinical practice. (отвара нови прозор)

González-López TJ, Alvarez-Román MT, Pascual C, Sánchez-González B, Fernández-Fuentes F, Pérez-Rus G, Hernández-Rivas JA, Bernat S, Bastida JM, Martínez-Badas MP, Martínez-Robles V, Soto I, Olivera P, Bolaños E, Alonso R, Entrena L, Gómez-Nuñez M, Alonso A, Yera Cobo M, Caparrós I, Tenorio M, Arrieta-Cerdán E, Lopez-Ansoar E, García-Frade J, González-Porras JR

Извор‎: Br J Haematol 2017;178(6):959-70.

Индекс‎: PubMed 28573819

DOI‎: 10.1111/bjh.14788

https://www.ncbi.nlm.nih.gov/pubmed/28573819 (отвара нови прозор)

Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. (отвара нови прозор)

Kojouri K, Vesely SK, Terrell DR, George JN.

Извор‎: Blood 2004;104(9):2623-34.

Индекс‎: PubMed 15217831

DOI‎: 10.1182/blood-2004-03-1168

https://www.ncbi.nlm.nih.gov/pubmed/15217831 (отвара нови прозор)

Romiplostim or standard of care in patients with immune thrombocytopenia. (отвара нови прозор)

Kuter DJ, Rummel M, Boccia R, Macik BG, Pabinger I, Selleslag D, Rodeghiero F, Chong BH, Wang X, Berger DP.

Извор‎: N Engl J Med 2010;363(20):1889-99.

Индекс‎: PubMed 21067381

DOI‎: 10.1056/NEJMoa1002625

https://www.ncbi.nlm.nih.gov/pubmed/21067381 (отвара нови прозор)

Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience. (отвара нови прозор)

Mazzucconi MG, Fazi P, Bernasconi S, De Rossi G, Leone G, Gugliotta L, Vianelli N, Avvisati G, Rodeghiero F, Amendola A, Baronci C, Carbone C, Quattrin S, Fioritoni G, D'Alfonso G, Mandelli F; Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA) Thrombocytopenia Working Party.

Извор‎: Blood 2007;109(4):1401-7.

Индекс‎: PubMed 17077333

DOI‎: 10.1182/blood-2005-12-015222

https://www.ncbi.nlm.nih.gov/pubmed/17077333 (отвара нови прозор)

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. (отвара нови прозор)

Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA; American Society of Hematology.

Извор‎: Blood 2011;117(16):4190-207.

Индекс‎: PubMed 21325604

DOI‎: 10.1182/blood-2010-08-302984

https://www.ncbi.nlm.nih.gov/pubmed/21325604 (отвара нови прозор)

American Society of Hematology 2019 guidelines for immune thrombocytopenia. (отвара нови прозор)

Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, Cuker A, Despotovic JM, George JN, Grace RF, Kühne T, Kuter DJ, Lim W, McCrae KR, Pruitt B, Shimanek H, Vesely SK

Извор‎: Blood Adv 2019;3(23):3829-66.

Индекс‎: PubMed 31794604

DOI‎: 10.1182/bloodadvances.2019000966

https://www.ncbi.nlm.nih.gov/pubmed/31794604 (отвара нови прозор)

International consensus report on the investigation and management of primary immune thrombocytopenia. (отвара нови прозор)

Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ.

Извор‎: Blood 2010;115(2):168-86.

Индекс‎: PubMed 19846889

DOI‎: 10.1182/blood-2009-06-225565

https://www.ncbi.nlm.nih.gov/pubmed/19846889 (отвара нови прозор)

Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. (отвара нови прозор)

Scaradavou A, Woo B, Woloski BM, Cunningham-Rundles S, Ettinger LJ, Aledort LM, Bussel JB.

Извор‎: Blood 1997;89(8):2689-700.

Индекс‎: PubMed 9108386

https://www.ncbi.nlm.nih.gov/pubmed/9108386 (отвара нови прозор)